As an optometrist, Dr. Janet Baker is passionate about eye care.
When we spoke this week, the Texas State Optical doctor was thrilled to share how pharmaceutical companies, aging baby boomers, and our addiction to devices have created a leap in patient care options.
“It’s the baby boomers that are pushing this a lot,” she said. “There is also such a large group of our patients who are over 40 and over 50 who have never had eye problems and can no longer see their devices. They want to be able to see and they are not used to wearing glasses. We give them options.
To meet this demand, says Baker, pharmaceutical companies are evolving with new drugs that are becoming more accessible to the eye care industry.
“Our role is to have all of this equipment available and to make sure our patients use it in a safe way and to make sure they get the prescriptions they need and the follow-up care,” Baker said.
“What you see is that pharmaceutical companies are, all of a sudden, more interested in how they can meet eye care needs.”
However, eye care cannot wait for a problem to arise; yet parents and young adults often make this mistake.
It is an omission that goes against basic baby care and paediatricians, who see our most precious children being regularly checked for eye response during normal visits.
Baker said optometrists are seeing more children starting school programs that use laptops and devices for the majority of the work.
“Of particular concern to school-aged children are the effects of blue emissions from devices that have not been fully explored,” she said.
“We don’t know what the long-term effects are. We are genuinely interested in protecting our children from any long term effects there.
Blue light exposure from screens is small compared to the amount of sun exposure, according to health experts; however, there are concerns about the long-term effects of screen exposure, particularly with excessive screen time and when a screen is too close to the eyes.
Because of this and so many other new concerns for 2022, Baker said Texas State Optical is keeping abreast of the latest trends in eye health and eye care.
She said the US Food and Drug Administration has approved drops that relieve droopy eyelids.
“It gives patients more options,” she said. “Instead of having surgeries, they can come and get these drops. It works like an eyelift. These are really new to the market.
The latest FDA-approved drop, Baker said, is one called Vuity that treats a condition called presbyopia.
Most people over the age of 40 suffer from this condition, where you have reduced accommodation for reading.
“It’s a drop that can actually act like reading glasses,” Baker said. “Instead of having to put on glasses or contacts, you can use a drop that helps correct your near vision. There are many new pharmaceuticals on the market, and we certainly make them all available to our patients at TSO. »
According to Baker, optometry has always treated glaucoma and myopia using pharmaceuticals. But this industry’s recent investment in eye care has created so many more options for patients looking for answers.
To learn more, visit Texas State Optical at 8700 Central Mall Drive in Port Arthur, call 409-515-7386, or log on to tso.com.
You have so many more opportunities to see clearly.
Stephen Hemelt is president of Port Arthur Newsmedia, which publishes panews.com and The Port Arthur News. He can be reached at [email protected] or 409-721-2445.